• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

PharmaJet expands needle-free delivery of influenza vaccines

February 15, 2017 By Sarah Faulkner

PharmaJet expands needle-free delivery of influenza vaccinesPharmaJet said today that a trivalent and quadrivalent influenza vaccine is available with its Stratis needle-free injector for this year’s flu season.

PharmaJet’s device is designed to administer medication intramuscularly or subcutaneously, without the use of needles. The Chicago-based company touts the technology as a way to prevent cross-contamination between needles and enhance patient compliance.

“The addition of a quadrivalent influenza vaccine gives healthcare providers a wider choice of vaccines that they can deliver without a needle,” PharmaJet chairman & CEO Ron Lowy said in prepared remarks. “PharmaJet offers the only needle-free delivery system approved by the FDA for administration of inactivated influenza vaccines.  Expanding the vaccine selection that can be used with our device is another significant step toward improving public health through expanded immunization coverage, as well as improved safety of caregivers.”

In October last year, the company inked a collaborative deal with Vaccibody to provide needle-free injection tech for the development of a human papillomavirus vaccine.

HPV is the cause of virtually all cervical cancer, according to the National Cancer Institute, and just 2 types of HPV, 16 and 18, are responsible for about 70% of all cases.

In August last year, PharmaJet landed a multi-year partnership with the World Health Organization as part of the group’s effort to eradicate polio using the company’s needle-free tech.

Filed Under: Drug-Device Combinations, Featured, Pharmaceuticals, Wall Street Beat Tagged With: PharmaJet

IN CASE YOU MISSED IT

  • Omnipod 5 rollout for type 2 rolls on as Insulet pursues next-gen automation
  • LifePlus reports clinical validation of non-invasive glucose, blood pressure monitor
  • Abbott Diabetes head talks Medtronic partnership, exciting times ahead
  • PharmaSens, SiBionics innovatively combine tech in all-in-one insulin patch pump
  • Study backs Biolinq intradermal sensor in muscle loss prevention during GLP-1 therapy

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS